BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30192121)

  • 1. HUMAN KARYOTYPE ANALYSIS IN DIAGNOSIS VERIFICATION.
    Gayner TA; Matveeva VG; Karimov OG; Shorina AR; Rubtsov NB; Karamysheva TV
    Tsitologiia; 2016; 58(6):482-7. PubMed ID: 30192121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of marker chromosomes using molecular cytogenetic methods in patients with mental retardation and congenital malformations].
    Bocian E; Nowakowska B; Obersztyn E; Borg K; Chudoba I; Kostyk E; Kruczek A; Pietrzyk J; Mazurczak T
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):211-25. PubMed ID: 17028390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supernumerary marker chromosomes detected in 100,000 prenatal diagnoses: molecular cytogenetic studies and clinical significance.
    Huang B; Solomon S; Thangavelu M; Peters K; Bhatt S
    Prenat Diagn; 2006 Dec; 26(12):1142-50. PubMed ID: 17009345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.
    Djordjevic V; Dencic-Fekete M; Jovanovic J; Bizic S; Jankovic G; Bogdanovic A; Cemerikic-Martinovic V; Gotic M
    Cancer Genet Cytogenet; 2007 Feb; 173(1):57-62. PubMed ID: 17284371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype.
    Yang X; Li R; Fu F; Zhang Y; Li D; Liao C
    J Matern Fetal Neonatal Med; 2017 Jan; 30(2):194-198. PubMed ID: 26998667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Future aspect of cytogenetics using chromosomal microarray testing].
    Yamamoto T
    Rinsho Byori; 2014 Jan; 62(1):75-82. PubMed ID: 24724430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis and molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome derived from chromosome 16.
    Chen CP; Ko TM; Chern SR; Wu PS; Chen SW; Lai ST; Yang CW; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):545-549. PubMed ID: 28805616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic elaboration of a novel reciprocal translocation in sheep.
    Iannuzzi A; Perucatti A; Genualdo V; De Lorenzi L; Di Berardino D; Parma P; Iannuzzi L
    Cytogenet Genome Res; 2013; 139(2):97-101. PubMed ID: 23328281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular cytogenetic analysis for a familial complex chromosomal rearrangement].
    Qian WP; Tan YQ; Tjia WM; Song D; Guan XY; Lu GX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):302-4. PubMed ID: 15952121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
    Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
    Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of partial trisomy 16q24.1-qter: clinical report and review of the literature.
    Brisset S; Joly G; Ozilou C; Lapierre JM; Gosset P; LeLorc'h M; Raoul O; Turleau C; Vekemans M; Romana SP
    Am J Med Genet; 2002 Dec; 113(4):339-45. PubMed ID: 12457405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal detection of complex chromosomal aberrations using advanced molecular cytogenetic techniques.
    de Pater JM; Govaerts LC; de Man SA; van der Sijs-Bos CJ; Christiaens GC; van Dam WM; Loneus WH; Engelen JJ
    Prenat Diagn; 2003 Sep; 23(9):747-51. PubMed ID: 12975787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular cytogenetic studies in a case with partial trisomy 12p due to a de novo supernumerary ring chromosome.
    Ausems MG; Schuil J; Van Raveswaaij-Arts C; De Pater JM
    Genet Couns; 2004; 15(4):405-10. PubMed ID: 15658615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the frequencies of prenatally diagnosed fetal chromosomal abnormalities at a single institution.
    Wu Q; Wang W; Kong H; Sun L; Ge Y; Xu Y; Zhou Y
    Fetal Pediatr Pathol; 2013 Jun; 32(3):163-8. PubMed ID: 22607389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic study on 53 patients with multiple myeloma].
    Jing Y; Fang MY; Jiang F; Lin S; Wang FT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):68-72. PubMed ID: 21362224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome Recognition.
    Wan TS; Hui EK; Ng MH
    Methods Mol Biol; 2017; 1541():67-74. PubMed ID: 27910015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
    Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
    Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal cytogenetic abnormalities are predictor in developing non-Hodgkin lymphomas?
    Wang Y; Xiao Y; Meng X; Zhang H; Li Q; Meng F; Huang L; Li C; Zhou J
    Exp Mol Pathol; 2017 Feb; 102(1):146-155. PubMed ID: 28087391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.